VM
STRO icon

VV Manager’s Sutro Biopharma STRO Stock Holding History

VV Manager’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2.84M Sell
36,566
-9,920
-21% -$952K 2.49% 4
2020
Q1 		$4.74M Sell
46,486
-53,072
-53% -$5.58M 5.36% 4
2019
Q4 		$11M Hold
99,558
– – 8.72% 4
2019
Q3 		$9.05M Hold
99,558
– – 6.73% 3
2019
Q2 		$11.3M Hold
99,558
– – 6.14% 3
2019
Q1 		$11.3M Hold
99,558
– – 4.45% 3
2018
Q4 		$8.98M Buy
+99,558
New +$12M 3.85% 3

Other funds holding STRO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VV Manager's STRO Position: Q2 2020 in Review

VV Manager reduced its Sutro Biopharma (STRO) stake by 21% in Q2 2020, selling an estimated $952K and leaving 36,566 shares worth $2.84M. The position accounts for 2.49% of the portfolio, ranked #4.

VV Manager first reported a position in STRO in Q4 2018 and has held it in 7 quarters since. The position peaked at $11.3M in Q1 2019. 80 funds tracked by Wall St. Rank hold STRO as of Q2 2020.

  • VV Manager held 36,566 shares of Sutro Biopharma worth $2.84M as of Q2 2020.
  • VV Manager sold 9,920 Sutro Biopharma shares in Q2 2020, an estimated $952K.
  • Sutro Biopharma made up 2.49% of VV Manager's portfolio in Q2 2020, its #4 holding.
  • VV Manager first reported a position in Sutro Biopharma in Q4 2018 and has held it in 7 quarters since.
  • VV Manager's Sutro Biopharma position peaked at $11.3M in Q1 2019.
  • 80 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2020.

Based on VV Manager's 13F filing for Q2 2020, filed 4 Aug 2020.